Simufilam

Simufilam was first introduced as having the potential to reduce biomarkers of Alzheimer's disease. The original data has since become suspect and could not be found. Fraud charges have been filed by the SEC. Simufilam may or may not have some useful bioactivities. The proper research, with proper data collection and analysis, is still to be done. SMILES: CN1CCC2(CC1)NCC(=O)N2CC3=CC=CC=C3